BrainCheck
PrivateLast Round
Series A
Feb 26, 2026
Total Funding Raised
$49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BrainCheck is a healthcare technology company that provides a digital platform for cognitive assessment and care planning to help clinicians screen, monitor, and manage patient brain health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainCheck Comparables
Compare BrainCheck with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Linus Health | 89% | |
| Creyos | 86% | |
| Altoida, Inc. | 83% |
BrainCheck Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 26, 2026 | ||||
| Series B Extension | Mar 6, 2024 | ||||
| Early Stage VC | Jan 5, 2024 | ||||
| Series B | Nov 3, 2021 | ||||
| Series A | Oct 9, 2019 | ||||
Seed | Oct 27, 2016 |
Key People
Founding team and executive leadership
BrainCheck Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nueterra Capital | Series B, Series A |
| Next Coast Ventures | Series A, Series B Extension, Series B, Early Stage VC |
| True Wealth Ventures | Series B, Series A |
| Texas Medical Center | Seed |
| Tensility Venture Partners | Series B, Series A |
| UPMC Enterprises | Series A, Series B, Series B Extension, Early Stage VC |
| S3 Ventures | Series A, Series B Extension, Series B, Early Stage VC |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Grew 31% QoQ, from 59 to 77 employees.
- Feb 26, 2026
$13M round completed.
Recent news
Latest coverage and updates
- attends_eventJul 7, 2026
BrainCheck, Inc. attended event 2026 Alzheimer's Association International Conference on Jul 12th '26.
BrainCheck Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BrainCheck's valuation, stock price, and market status.
Is BrainCheck a public or private company?
BrainCheck is a private company.
What is the current stock price of BrainCheck?
BrainCheck is a private company with no public stock price. No recent secondary market data is available.
How much is BrainCheck worth (valuation)?
Valuation information for BrainCheck is not publicly available.
Can I buy BrainCheck stock?
BrainCheck shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BrainCheck's last funding round?
BrainCheck's most recent funding round was Series A on February 26, 2026.
Who are the main investors in BrainCheck?
Key investors in BrainCheck include Next Coast Ventures, Tensility Venture Partners, UPMC Enterprises, S3 Ventures.
Will BrainCheck IPO soon?
No public IPO plans have been announced for BrainCheck.
How can I track BrainCheck secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BrainCheck's secondary market activity and sign up for updates.